| 仑伐替尼联合TACE辅助治疗术后高复发风险肝细胞癌患者：LANCE研究结果更新 |
| |
| 引用本文： | 张必翔,邹威.仑伐替尼联合TACE辅助治疗术后高复发风险肝细胞癌患者：LANCE研究结果更新[J].循证医学,2021,21(6):329-331. |
| |
| 作者姓名： | 张必翔 邹威 |
| |
| 作者单位： | 1.华中科技大学同济医学院附属同济医院肝脏外科中心, 武汉 430030; 2.广东省人民医院综合（介入）肿瘤一科, 广州510080 |
| |
| 摘 要： |
|
| 关 键 词： | 肝细胞癌 仑伐替尼 肝动脉化疗栓塞 |
Adjuvant Lenvatinib in Combination With TACE for HCC Patients With High Risk of Postoperative Relapse： Updated of LANCE Study |
| |
| ZHANG Bi-xiang,ZOU Wei.Adjuvant Lenvatinib in Combination With TACE for HCC Patients With High Risk of Postoperative Relapse： Updated of LANCE Study[J].The Journal of Evidence-Based Medicine,2021,21(6):329-331. |
| |
| Authors: | ZHANG Bi-xiang ZOU Wei |
| |
| Institution: | Reviewer's address： Department of Surgery, Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China |
| |
| Abstract: | |
| |
| Keywords: | hepatocellular carcinoma lenvantinib transarterial chemoembolization |
|
| 点击此处可从《循证医学》浏览原始摘要信息 |
| 点击此处可从《循证医学》下载免费的PDF全文 |
|
